Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
Insilico Medicine has completed first-in-human dosing in the Phase I clinical study of ISM8969, an AI-driven small-molec...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
MindWalk Holdings Corp. is positioning biological data infrastructure as a key bottleneck in AI-enabled drug discovery, ...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
Genentech has received U.S. FDA acceptance and Priority Review for its New Drug Application for giredestrant as an adjuv...
Nuvalent has received U.S. FDA acceptance and Priority Review for its New Drug Application for neladalkib in tyrosine ki...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
The European Medicines Agency has accepted Teva’s Marketing Authorisation Application for olanzapine long-acting i...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...
MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...
Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
4D Path, a US-based company dedicated to personalising cancer care through a novel, physics-informed approach to predict...
